1 day Ago By Roland Hutchinson
As the anticipated release of the Series 11 approaches in 2025, rumors and speculation are swirling around the potential inclusion of non-invasive glucose monitoring. This groundbreaking feature, which would allow users to track their blood sugar levels without the need for needles or skin penetration, has the potential to transform diabetes management and metabolic health tracking. However, recent reports suggest that this highly sought-after technology may not be ready for consumer use in the upcoming Series 11.
the video below from Matt Talks Tech gives us more details on the device. While Apple has reportedly achieved a proof of concept for non-invasive glucose monitoring using optical sensors, significant challenges remain in terms of accuracy and reliability. These hurdles are not unique to Apple, as competitors like Samsung are also working on similar solutions.
Given the current state of the technology, it is unlikely that the Series 11 will include a fully functional glucose monitoring sensor. Instead, this innovation may be reserved for future Apple Watch models. To understand what the Series 11 might offer, it is helpful to look back at the Apple Watch Series 10, which launched in early 2024.
The Series 10 introduced the first major redesign since the Series 4, featuring: A slimmer profile, approximately 10% thinner than its predecessor A larger display that rivaled the Apple Watch Ultra Elevated aesthetics and usability, setting a new standard for Apple’s smartwatch lineup While the redesign was well-received, the Series 10 fell short in other areas. It did not deliver significant upgrades in battery life or health sensors, leaving some users underwhelmed. The absence of groundbreaking features fueled speculation about what the Series 11 might bring to the table.
Based on leaks and rumors, the Apple Watch Series 11 is expected to launch alongside the in September 2025. The watch will likely retain the slimmer profile and larger 10. While these design elements have been praised, they are not new, and the Series 11 may lack significant hardware upgrades or new health sensors.
Apple might introduce minor updates, such as new color options, to refresh the lineup. However, pricing is expected to remain consistent with the Series 10, signaling that the Series 11 will prioritize . For those eager to monitor their blood sugar levels, third-party devices like Dexcom patches offer a practical solution.
These devices integrate seamlessly with Apple Watches and iPhones, providing real-time glucose data through wireless connectivity. While not as convenient as a built-in sensor, they highlight Apple’s commitment to supporting health-focused technology within its ecosystem. Battery life continues to be a critical factor for smartwatch users.
Despite the Series 10’s design improvements, it did not deliver notable gains in this area. The Series 11 is unlikely to introduce major advancements in battery performance, as Apple seems to prioritize design and functionality over extended usage times. Apple is not the only player in the wearable health tech space.
Samsung, in particular, is making strides in non-invasive glucose monitoring, posing a challenge to Apple’s dominance. As both companies race to integrate this feature into their devices, consumers stand to benefit from increased innovation and competition. The 11 appears to be an rather than a groundbreaking release.
While the idea of non-invasive glucose monitoring is exciting, it is unlikely to materialize in this iteration. Instead, the Series 11 will likely refine the design and functionality introduced with the Series 10, maintaining Apple’s reputation for high-quality wearable technology. For now, non-invasive glucose monitoring remains a work in progress.
As Apple and its competitors tackle the technical challenges, this feature could redefine wearable health technology in the future. If you are considering the Series 11, keep an eye on these developments—they may shape the . Source & Image Credit:.
